BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21769056)

  • 1. A nonopioid procedure for outpatient opioid detoxification.
    Ockert DM; Volpicelli JR; Baier AR; Coons EE; Fingesten A
    J Addict Med; 2011 Jun; 5(2):110-4. PubMed ID: 21769056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
    Collins ED; Kleber HD; Whittington RA; Heitler NE
    JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
    Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R
    J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three methods of opioid detoxification in a primary care setting. A randomized trial.
    O'Connor PG; Carroll KM; Shi JM; Schottenfeld RS; Kosten TR; Rounsaville BJ
    Ann Intern Med; 1997 Oct; 127(7):526-30. PubMed ID: 9313020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine.
    Sullivan M; Bisaga A; Pavlicova M; Choi CJ; Mishlen K; Carpenter KM; Levin FR; Dakwar E; Mariani JJ; Nunes EV
    Am J Psychiatry; 2017 May; 174(5):459-467. PubMed ID: 28068780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination very low-dose naltrexone-clonidine in the management of opioid withdrawal.
    Mannelli P; Peindl K; Wu LT; Patkar AA; Gorelick DA
    Am J Drug Alcohol Abuse; 2012 May; 38(3):200-5. PubMed ID: 22233189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of trazodone-naltrexone versus clonidine-naltrexone in rapid withdrawal from methadone treatment. A comparative inpatient study.
    Pozzi G; Conte G; De Risio S
    Drug Alcohol Depend; 2000 Jun; 59(3):287-94. PubMed ID: 10812288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorder.
    Sibai M; Mishlen K; Nunes EV; Levin FR; Mariani JJ; Bisaga A
    Am J Drug Alcohol Abuse; 2020 May; 46(3):289-296. PubMed ID: 31860366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient opiate detoxification with clonidine.
    Washton AM; Resnick RB
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):39-41. PubMed ID: 7085584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting completion of outpatient opioid detoxification with clonidine.
    Strobbe S; Brower KJ; Galen LW
    Am J Addict; 2003; 12(3):260-9. PubMed ID: 12851022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient versus inpatient opioid detoxification: a randomized controlled trial.
    Day E; Strang J
    J Subst Abuse Treat; 2011 Jan; 40(1):56-66. PubMed ID: 21036514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary care-based ambulatory opioid detoxification: the results of a clinical trial.
    O'Connor PG; Waugh ME; Carroll KM; Rounsaville BJ; Diagkogiannis IA; Schottenfeld RS
    J Gen Intern Med; 1995 May; 10(5):255-60. PubMed ID: 7616334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence.
    Ziedonis DM; Amass L; Steinberg M; Woody G; Krejci J; Annon JJ; Cohen AJ; Waite-O'Brien N; Stine SM; McCarty D; Reid MS; Brown LS; Maslansky R; Winhusen T; Babcock D; Brigham G; Muir J; Orr D; Buchan BJ; Horton T; Ling W
    Drug Alcohol Depend; 2009 Jan; 99(1-3):28-36. PubMed ID: 18805656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient non-opioid detoxification for opioid withdrawal. Who is likely to benefit?
    McCann MJ; Miotto K; Rawson RA; Huber A; Shoptaw S; Ling W
    Am J Addict; 1997; 6(3):218-23. PubMed ID: 9256987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline characteristics of patients predicting suitability for rapid naltrexone induction.
    Mogali S; Khan NA; Drill ES; Pavlicova M; Sullivan MA; Nunes E; Bisaga A
    Am J Addict; 2015 Apr; 24(3):258-264. PubMed ID: 25907815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical use of clonidine in outpatient detoxification from opiates.
    Washton AM; Resnick RB
    Prog Clin Biol Res; 1981; 71():277-84. PubMed ID: 7330080
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of rapid (opioid) detoxification with clonidine-assisted detoxification for heroin-dependent persons.
    Arnold-Reed DE; Hulse GK
    J Opioid Manag; 2005; 1(1):17-23. PubMed ID: 17315407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of induction onto extended-release naltrexone among unemployed heroin-dependent adults.
    Jarvis BP; Holtyn AF; Berry MS; Subramaniam S; Umbricht A; Fingerhood M; Bigelow GE; Silverman K
    J Subst Abuse Treat; 2018 Feb; 85():38-44. PubMed ID: 28449955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
    Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inpatient initiation of buprenorphine maintenance vs. detoxification: can retention of opioid-dependent patients in outpatient counseling be improved?
    Caldiero RM; Parran TV; Adelman CL; Piche B
    Am J Addict; 2006; 15(1):1-7. PubMed ID: 16449087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.